{"text": "We propose a role as early prognostic biomarkers for pERK protein levels in adenocarcinoma, and for nuclear p53 levels in squamous cell lung carcinoma. The determination of these potential biomarkers in the adequate histologic context may predict the outcome of early stage NSCLC patients, and may offer a therapeutic opportunity to enhance survival of these patients.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 53, "end": 57}}, {"id": "T2", "obj": "disease", "span": {"begin": 76, "end": 90}}, {"id": "T3", "obj": "disease", "span": {"begin": 122, "end": 150}}, {"id": "T4", "obj": "disease", "span": {"begin": 274, "end": 288}}]}
